Media type: E-Article Title: Risk Factors for Relapses After Switching From Natalizumab To Fingolimod (P7.241) Contributor: Havla, Joachim; Hoepner, Robert; Eienbröker, Christian; Tackenberg, Bjorn; Hellwig, Kerstin; Meinl, Ingrid; Gold, Ralf; Hohlfeld, Reinhard; Kuempfel, Tania; Kleiter, Ingo imprint: Ovid Technologies (Wolters Kluwer Health), 2014 Published in: Neurology Language: English DOI: 10.1212/wnl.82.10_supplement.p7.241 ISSN: 0028-3878; 1526-632X Keywords: Neurology (clinical) Origination: Footnote: